Reminder: US FDA Drug Listing Renewals 2026

Reminder: US FDA Drug Listing Renewals 2026

As the annual renewal period approaches, companies marketing drugs in the US should begin reviewing their FDA establishment registrations and drug listings. The annual renewal period runs from October 1 through December 31, 2026. During this period, companies should...